Literature DB >> 15135555

Psychopathology and treatment outcome of drug dependent women in a perinatal program.

Karen S Ingersoll1, Janet S Knisely, Kathryn S Dawson, Sidney H Schnoll.   

Abstract

One hundred and five drug-dependent women in outpatient perinatal addiction treatment were classified by cluster analysis of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) profiles into high and low psychopathology (HP and LP) groups that differed on three validation measures. The HP group (n=29, 27.6%) had elevations on MMPI-2 Scales F, 2, 4, 6, 7, and 8, while the LP group (n=76, 72.4%) generated a normal range profile with elevations on Scales F and 4. Psychological outcomes differed by group. HP participants showed reduced alcohol, family, and psychiatric severity, and reduced depressive symptoms, while LP subjects showed reduced drug, self-debasing, and acting-out problems. Data suggest the need for lower intensity services for the majority of the perinatal drug dependent population with LP.

Entities:  

Mesh:

Year:  2004        PMID: 15135555      PMCID: PMC2868062          DOI: 10.1016/j.addbeh.2004.02.002

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  14 in total

1.  A comparison study of treated and untreated pregnant and postpartum cocaine-abusing women.

Authors:  I E Smith; D Z Dent; C D Coles; A Falek
Journal:  J Subst Abuse Treat       Date:  1992

2.  Preliminary typology designed for treatment matching of driving-while-intoxicated offenders.

Authors:  W F Wieczorek; B A Miller
Journal:  J Consult Clin Psychol       Date:  1992-10

Review 3.  Patient treatment matching: a conceptual and methodological review with suggestions for future research.

Authors:  A T McLellan; A I Alterman
Journal:  NIDA Res Monogr       Date:  1991

4.  A comparison of male and female cocaine abusers.

Authors:  M L Griffin; R D Weiss; S M Mirin; U Lange
Journal:  Arch Gen Psychiatry       Date:  1989-02

5.  Increased effectiveness of substance abuse treatment. A prospective study of patient-treatment "matching".

Authors:  A T McLellan; G E Woody; L Luborsky; C P O'Brien; K A Druley
Journal:  J Nerv Ment Dis       Date:  1983-10       Impact factor: 2.254

6.  Sex differences in cocaine use and experiences: a double standard revived?

Authors:  P G Erickson; G F Murray
Journal:  Am J Drug Alcohol Abuse       Date:  1989       Impact factor: 3.829

7.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

8.  Neurogenetic adaptive mechanisms in alcoholism.

Authors:  C R Cloninger
Journal:  Science       Date:  1987-04-24       Impact factor: 47.728

9.  Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity.

Authors:  A T McLellan; L Luborsky; G E Woody; C P O'Brien; K A Druley
Journal:  Arch Gen Psychiatry       Date:  1983-06

Review 10.  Residential therapeutic communities for female substance abusers.

Authors:  G De Leon; N Jainchill
Journal:  Bull N Y Acad Med       Date:  1991 May-Jun
View more
  3 in total

1.  Major depressive disorder during pregnancy and emotional attachment to the fetus.

Authors:  Julie McFarland; Amy L Salisbury; Cynthia L Battle; Katheleen Hawes; Katherine Halloran; Barry M Lester
Journal:  Arch Womens Ment Health       Date:  2011-09-22       Impact factor: 3.633

Review 2.  Maternal substance use and integrated treatment programs for women with substance abuse issues and their children: a meta-analysis.

Authors:  Karen Milligan; Alison Niccols; Wendy Sword; Lehana Thabane; Joanna Henderson; Ainsley Smith; Jennifer Liu
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-09-01

3.  Psychological features of abstinent heroin users before and after rehabilitation in Saint Petersburg, Russia.

Authors:  Timofey Galankin; Dmitry Lioznov; Svetlana Nikolaenko; Louise-Anne McNutt; Emily Leckman-Westin; Perry F Smith
Journal:  BMC Res Notes       Date:  2018-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.